XTalks

MAY 8, 2024

Dr. Schaffner and Dr. Moore discussed the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommendation of a trivalent influenza vaccine strain selection, as opposed to a typical quadrivalent vaccine, with the 2024/2025 influenza season reflecting the removal of the B/Yamagata strain.

Life Science 52

Life Science Vaccination Vaccine Medicine 52

XTalks

NOVEMBER 8, 2023

In this episode, Ayesha talked about the FDA’s acceptance of AstraZeneca’s supplemental biologics license application (sBLA) for a self-administered option of its nasal influenza vaccine FluMist Quadrivalent. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Vaccination Vaccine Licensing 52

Drug Discovery World

FEBRUARY 6, 2024

The Association of the British Pharmaceutical Industry (ABPI) has published a manifesto outlining what a UK government must do to make the country a great place to research and develop the medicines and vaccines of the future. The post The ABPI sets out a manifesto for UK life sciences appeared first on Drug Discovery World (DDW).

Life Science 52

Life Science Medicine Vaccination Vaccine 52

XTalks

DECEMBER 13, 2023

This episode features an interview with vaccine scientists and executives from Vaccines Global Clinical Development at Merck, Dr. Heather Platt, MD, Distinguished Scientist and Pneumococcal Vaccine Lead; and Dr. Ulrike Buchwald, MD, Scientific Associate Vice President, Global Clinical Research and Pneumococcal Vaccine Section Head.

Life Science 52

Life Science Vaccination Vaccine Scientist 52

Drug Discovery World

MARCH 7, 2023

For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. The life sciences sector has traditionally outperformed others when it comes to attracting women to its workforce. Dr Loubna Bouarfa, Founder and CEO, OKRA.ai

Life Science 98

Life Science DNA Clinical Development Development 98

XTalks

MARCH 26, 2021

With a number of COVID-19 vaccines now being authorized for use, how do we decide which is the best? Using data from COVID-19 vaccine trials from Pfizer/BioNTech, Oxford/AstraZeneca, Moderna and J&J, Ayesha explains why vaccine efficacies can’t be directly compared — and why vaccine messaging needs to reflect this.

Life Science 75

Life Science Vaccination Vaccine Trials 75

XTalks

DECEMBER 20, 2023

In 2023, there were significant advancements and notable trends in the life sciences. Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

Pharmaceutical Technology

MAY 23, 2023

Croda Pharma has entered a strategic collaboration deal with Botanical Solution Inc (BSI) to expedite the production of sustainable pharmaceutical-grade vaccine adjuvant QS-21. The plentiful supply of QS-21 enables the production of next-generation adjuvant systems for new vaccine development.”

Production 240

Production Vaccination Vaccine Life Science 240

XTalks

MARCH 8, 2022

On International Women’s Day, Xtalks is celebrating women’s leadership in the life sciences by highlighting some of the female leaders at the forefront of scientific discovery, as well as the continuing challenges of attaining more equitable representation. Challenges in Women’s Leadership.

Life Science 105

Life Science Gene Therapy DNA Vaccination 105

XTalks

OCTOBER 4, 2023

Elmar Joura, Associate Professor of Gynecology in the Department of Obstetrics and Gynecology at the Medical University of Vienna, who spoke to Xtalks about exciting new long-term Gardasil vaccine data from a study he led as principal investigator that showed the long-term impact of HPV vaccination.

Life Science 52

Life Science Vaccination Vaccine Antibody 52

XTalks

JANUARY 5, 2022

In the first episode of 2022, Ayesha provided updates on Omicron and COVID-19 vaccine boosters. Ayesha also discussed some of the predicted trends in the life sciences for 2022. Read the full articles here: FDA Authorizes COVID-19 Vaccine Booster for 12- to 15-Year-Olds, Shortens Booster Interval.

Life Science 52

Life Science RNA Vaccination Vaccine 52

BioSpace

JULY 12, 2022

In what seems like an unlikely collaboration, Seattle-based Fred Hutchinson Cancer Center (Fred Hutch) is partnering with Amazon to develop cancer vaccines.

Life Science 95

Life Science Vaccination Vaccine Development 95

XTalks

AUGUST 17, 2022

In this episode, Ayesha discussed the UK’s approval of Moderna’s next generation COVID-19 vaccine that targets both the original strain of SARS-CoV-2 and the Omicron variant of concern. As part of this, the health agencies suggest healthcare providers should ‘strongly recommend’ vaccines.

Life Science 52

Life Science Vaccination Vaccine Clinical Trials 52

XTalks

DECEMBER 8, 2021

Moderna’s CEO sparked concerns when he said the current vaccines likely won’t be effective against Omicron, while Pfizer’s CEO said vaccines for COVID-19 will likely be needed for many years. The team also talked about a new hepatitis B vaccine from VBI Vaccines that received FDA approval for adults.

Life Science 98

Life Science FDA Approval Vaccination Vaccine 98

XTalks

MAY 10, 2023

In this episode, Ayesha talked about the FDA approval of the world’s first vaccine for respiratory syncytial virus (RSV). The vaccine is approved for adults 60 years of age and older. Read more about the vaccine, including clinical trial results on its efficacy and safety.

Life Science 52

Life Science Vaccination Vaccine FDA Approval 52

Fierce Pharma

MARCH 6, 2024

s business environment for the life sciences industry, is directing a big chunk of money into the Big Pharma’s home country. s business environment for the life sciences industry, is directing £650 million into the Big Pharma’s home country. AstraZeneca CEO Pascal Soriot, who has been critical of the U.K.’s

Life Science 143

Life Science Vaccination Vaccine 143

XTalks

APRIL 7, 2021

In this episode of the Xtalks Life Science Podcast, Ayesha discusses a report from the Center for Countering Digital Hate (CCDH) and Anti-Vax Watch that shows there are just 12 people behind 65 percent of all online anti-vaccine disinformation. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 59

Life Science Vaccination Vaccine Trials 59

XTalks

JULY 20, 2022

In this episode, Ayesha discussed the FDA authorization of Novavax’s COVID-19 vaccine, making it the fourth authorized/approved COVID vaccine in the US. It is also the first protein-based COVID-19 vaccine to be authorized in the country. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Vaccination Vaccine Drugs 52

pharmaphorum

MARCH 12, 2021

If the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufactured have confirmed just how dynamic the industry can be. Building the data-powered life sciences business .

Life Science 111

Life Science Regulation Genome Genomics 111

XTalks

DECEMBER 17, 2021

Xtalks is taking a look at some of the major stories and innovations of the year in the life sciences, many of which were driven by new, emerging and improved technologies. The year continued to be dominated by COVID-19, and the second year of the pandemic was all about vaccines. COVID-19: The Pandemic and the Vaccines.

Life Science 98

Life Science Vaccination Vaccine Trials 98

XTalks

JULY 6, 2022

Ayesha also talked about the US Food and Drug Administration (FDA)’s amended authorizations for Pfizer-BioNTech’s and Moderna’s COVID-19 vaccines to include children as young as six months old. Hear about the vaccine trials and parents’ attitudes towards vaccinating younger children.

Life Science 52

Life Science Vaccination Vaccine Development 52

XTalks

NOVEMBER 23, 2022

Ayesha also talked about the latest positive Phase III trial data that Pfizer recently shared for its maternal RSV vaccine candidate. Hear more about the vaccine trial data, based on which an independent data monitoring committee has recommended that Pfizer file with the FDA for approval.

Life Science 52

Life Science FDA Approval Vaccination Vaccine 52

XTalks

AUGUST 18, 2021

In this episode, Ayesha discussed the US Food and Drug Administration’s (FDA) authorization of a third dose of the Pfizer and Moderna COVID-19 vaccines for immunocompromised individuals. The FDA said additional vaccine doses for the general public are currently unwarranted. Read the full article here: .

Life Science 52

Life Science Vaccination Vaccine Antibody 52

pharmaphorum

APRIL 4, 2022

Multinational insurance company AXA has launched a new €440 million ($500 million) drive to provide private equity investments in healthcare companies that deepens its interest in the life sciences sector. It is a major backer of Kadans, one of the groups behind the recently-announced Canary Wharf life sciences hub in east London.

Life Science 59

Life Science Vaccination Vaccine Marketing 59

XTalks

DECEMBER 29, 2022

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

BioSpace

MARCH 26, 2024

Moderna has entered into a development and commercialization funding agreement with asset management firm Blackstone Life Sciences to help advance its pipeline of flu vaccine candidates.

Life Science 134

Life Science Vaccination Vaccine Development 134

XTalks

APRIL 21, 2021

More cases of blood clots in those vaccinated against COVID-19 — this time in six women who took the J&J shot — has US regulators recommending that vaccination efforts be paused. US Regulators Recommend Pause on J&J’s COVID-19 Vaccine, But Just as a Precaution.

Life Science 52

Life Science Vaccination Vaccine FDA Approval 52

XTalks

FEBRUARY 19, 2024

Moderna has been testing an experimental mRNA vaccine aimed at combating the human cytomegalovirus (CMV), which poses significant health risks to newborns and immunocompromised patients. The team used the data and patient samples from a gB/MF59 Phase II trial in adolescent girls as a benchmark to assess the new mRNA-based vaccine.

Vaccination 59

Vaccination Vaccine Trials Clinical Trials 59

XTalks

MARCH 26, 2021

In Episode 3 of the Xtalks Life Science Podcast, the team reflects on the 1-year anniversary of the start of the COVID-19 pandemic. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. The 4 Biggest Cancer Biotech Acquisitions of 2021 So Far.

Life Science 76

Life Science Vaccination Vaccine Development 76

XTalks

APRIL 20, 2022

In this episode, Ayesha discussed BioNTech’s new collaboration with Matinas BioPharma to explore the company’s lipid nanocrystal (LNC) delivery technology for mRNA vaccines. LNC structures are more stable than the lipid nanoparticle technology used in the current COVID-19 mRNA vaccines. in a $525 million deal. in a $525 million deal.

Life Science 52

Life Science Vaccination Vaccine Development 52

pharmaphorum

DECEMBER 1, 2021

Bruntwood SciTech is the UK’s leading property provider dedicated to driving the growth of the science and technology sector. UK life sciences are buoyant with the success of the COVID-19 vaccine programme and a stream of innovation and investment marking it out for a starring role in the UK’s economic future.

Life Science 52

Life Science Vaccination Vaccine Development 52

XTalks

JULY 22, 2021

Soumya Swaminathan made comments in a press briefing about mixing and matching COVID-19 vaccines and how there is currently no data to support additional doses and boosters at this time. Misleading Headlines Lead to Confusion Over WHO Comments on Boosters and Mixing and Matching COVID-19 Vaccines.

Life Science 98

Life Science Vaccination Vaccine Scientist 98

XTalks

SEPTEMBER 29, 2021

The episode also features a discussion about Pfizer and BioNTech’s announcement of the first trial results for their COVID-19 vaccine in young children five to 11 years of age. The data shows that the vaccine is safe, well-tolerated and elicits robust immune responses in this age group.

Life Science 52

Life Science Vaccination Vaccine Immune Response 52

pharmaphorum

JUNE 3, 2021

The arrival of G7 health ministers to Oxford this week (Thursday 3 June) will shine a spotlight on Oxfordshire’s considerable achievements in the life sciences sector – and, according to the county’s Local Enterprise Partnership, there couldn’t be a better location globally for this summit to be held.

Life Science 52

Life Science Vaccination Vaccine Development 52

pharmaphorum

JULY 7, 2021

The UK’s long-awaited Life Sciences Vision strategy has been published, setting out the government’s stall as it tries to deliver on its promise to keep the country at the forefront of the sector. ” The post Dementia, cancer headline UK’s 10-year plan for life sciences sector appeared first on.

Life Science 59

Life Science Manufacturing Genome Genomics 59

BioTech 365

MARCH 4, 2021

MJH Life Sciences™ COVID-19 Coalition Partners With the International Society for Vaccines on Live Webinar Designed to Combat “Vaccine Hesitancy” MJH Life Sciences™ COVID-19 Coalition Partners With the International Society for Vaccines on Live Webinar Designed to Combat “Vaccine Hesitancy” … Continue reading →

Life Science 40

Life Science Vaccination Vaccine 40

Drug Discovery World

MAY 13, 2024

Reece Armstrong speaks to Melanie Adams-Cioaba , Senior Director and General Manager of pharma (cryo-EM), Thermo Fisher Scientific about advances in vaccine design. Using structural biology as central to vaccine design and development, and to drug discovery more generally, is what we mean by “rational design.”

Vaccination 57

Vaccination Vaccine Protein Antibody 57